Abstracts

Pediatric Oncology Improving the Outcome of Pediatric ALL by Transitioning From Nonuniform Chemotherapy Regimens to a Uniform Multicentric Protocol: A Comprehensive Experience from an Indian Center on the ICiCLe Protocol
Debabrata Mohapatra • Rachna Seth • Amitabh Singh • Prashant Prabhakar • Nivedita Pathak • Manisha Aggarwal • Jagdish Prasad Meena • Aditya Kumar Gupta • Tincy Jobin • Ritu Gupta
doi.org/10.69690/ODMJ-018-0425-1174
Pediatric Oncology Molecular Profile of Pediatric Acute Lymphoblastic Leukemia: A retrospective study from Tertiary Care Centre of Kashmir
Faisal Guru • Syed Nisar • Shumail Bashir • Ulfat Aara • Mir Mohammad Hussain • Sunil Regmi
doi.org/10.69690/ODMJ-018-0425-647
Pediatric Oncology Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups: Experience in a tertiary level pediatric hospital in Bangladesh
Md. Belayet Hossain • Abdul Wohab • Umme Nushrat • Sajeda Sultana • Nilufer Aktar
doi.org/10.69690/ODMJ-018-0425-1571-1790
Pediatric Oncology Radioiodine Therapy for Thyroid Cancer in Children
Tamara Geliashvili • Aleksey Li • Vadim Ilyakov • Olga Baranova • Michail Goncharov • Alexander Parnas • Vladimir Polyakov • Natalya Ivanova • Vladimir Korolev
doi.org/10.69690/ODMJ-018-0425-520
Pediatric Oncology Managing Myxopapillary Ependymomas in Children: The Experience of a Single Center
Igor Kasich • Ekaterina Salnikova • Vladimir Gornostaev • Irina Vilesova • Arthur Merishavyan • Alexey Dubskikh • Alexander Druy • Galina Novichkova • Alexander Karachunskiy • Lyudmila Papusha • Nikolay Grachev
doi.org/10.69690/ODMJ-018-0425-637
Pediatric Oncology Prognostic Significance of CD79a Expression in Paediatric B-Cell Acute Lymphoblastic Leukaemia: Implications for Risk Stratification and Therapeutic Targeting
Muhammad Alsabagh • Asmaa Hamoda • Eman Kandel • Sally Talaat
doi.org/10.69690/ODMJ-018-0425-378
Pediatric Oncology Enhancing Chemosensitivity in Pediatric Cancers: Investigating the Role of SLFN11 in Response to DNA-Damaging Agents and PARP Inhibitors
Christophe Raynaud • Ayesha Jabeen • Dina Awartani • Eiman Ahmed • Shimaa Sherif • Apryl Sanchez • Wouter Hendrickx
doi.org/10.69690/ODMJ-018-0425-806
Pediatric Oncology Outcome of Unrelated Umbilical Cord Blood Transplantation in India: A less explored horizon
Debabrata Mohapatra • Deepam Pushpam • Ranjit Kumar Sahoo • Sameer Bakhshi
doi.org/10.69690/ODMJ-018-0425-1168
Pediatric Oncology Rearrangements of the KMT2A Gene in Acute Leukemia in Children – Determination in Whole Genome Sequencing Data and Clinical Application
Elena Zerkalenkova • Karina Ilyasova • Olga Soldatkina • Anna Kazakova • Yulia Olshanksaya • Irina Kalinina • Aleksey Maschan • Galina Novichkova
doi.org/10.69690/ODMJ-018-0425-628
Pediatric Oncology Radiation Therapy to Metastatic Sites Among Patients with High-Risk Neuroblastoma in First-Line Therapy
Tatyana Shamanskaya • Yulia Voevodina • Anastasia Usychkina • Yury Likar • Chaurasiya Kailash • Maxim Dunaykin • Denis Kachanov • Alexey Nechesnyuk
doi.org/10.69690/ODMJ-018-0425-510
Pediatric Oncology Retinoblastoma Presentations-Looks Can Be Deceiving
Shabana Chaudhry • Aisha Azam • Andleeb Zahra • Samreen Jamal • Asim Amjad
doi.org/10.69690/ODMJ-018-0425-1775
Pediatric Oncology Multi-disciplinary Management of Children with Wilms’ Tumor: A real-world evidence from a tertiary cancer care center in Southern India
Prasanth Srinivasan • Gargi Das • Balaji Thiruvengadam Kothandan • Anand Raja • Venkatraman Radhakrishnan
doi.org/10.69690/ODMJ-018-0425-1044